
HSBC Continental Europe, acting as Stabilisation Coordinator, announced that it and several banks may stabilise the market for Sanofi's fixed-rate bonds due in 2029, 2033, and 2037. The stabilisation period is set to start on April 24, 2026, and end no later than June 4, 2026, with a 5% over-allotment facility available. This action aims to support the bond prices during the offer but is not guaranteed to occur. The announcement is informational and not an offer to buy or sell securities.